Sutro Biopharma (STRO) PT Raised to $41 at Citizens

April 23, 2026 8:51 AM

Citizens analyst Reni Benjamin raised the price target on Sutro Biopharma (NASDAQ: STRO) to $41.00 (from $35.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found